Skip to main content
OpenTrials

Clinical trial condition

HER2-positive Newly Diagnosed, Primary Breast Cancer

Explore clinical trials studying HER2-positive Newly Diagnosed, Primary Breast Cancer. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies
Refine in advanced search Browse all conditions

HER2-positive Newly Diagnosed, Primary Breast Cancer trial results

Completed

NeoPHOEBE: Neoadjuvant Trastuzumab + BKM120 in Combination With Weekly Paclitaxel in HER2-positive Primary Breast Cancer

NCT01816594

Conditions
Breast Diseases, Breast Neoplasms, HER2-positive Newly Diagnosed, Primary Breast Cancer, +4 more
Locations
  • Novartis Investigative Site Parkville, Victoria, Australia
  • Novartis Investigative Site Parkville, Victoria, Australia
  • Novartis Investigative Site Salzburg, Austria
  • Novartis Investigative Site Lübeck, Germany
View Trial Details

Related conditions